The validation of Lyn in the human cell lines was complicated by limited antibody sensitivity and differential antibody binding to human and mouse Lyn, but with a possible trend towards p190 ( Supplementary Figure S3 ).
← all excerpts
Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics.
1
—
—